Berkeley Lights Inc (BLI) 52week low will we see more red or green?

   

MARKET-TIME = NASDAQ: $BLI) 23.53 USD -12.33 (-34.38%) = each week we can see a company that has release more and more content but no type of "interest" for firms or big shark investors to hold but rather sell like Taco-bell menu of nacho fries. This City is a liberal land and might have issue with many things in the future due to the state of the elites run by Newsom rules. The company is burning more cash like it seem and CEO are enjoying it. I will keep this as radar but I have a feeling we won't be seeing a good PR or news to boost this back up to $25+. I will just shut this down and wait until it drop by boards to CEO selling shares. Remember this is Biotech and USA are not focus on cells" right now. Who hold above 20+ will be walking to BEAR-GATES... 

you can see this chart, this company is walking to BEAR-GATES... we might see lowest to low soon this year or next until the biotech industry focus on "cells". So many other biotech companies has drop without any type of government contracts or new firm investors. I will keep this in radar but wait until the huge drop come. Remember long, is ok to sell as a loss you will buy it again when the price is right . Remember my option I will see around $6 or under. After-hours show move bleeding then later we will see more on premarket... Stay bless and take a loss the long, its no light here for a bit, speaking facts right now. This company is large market-cap so it might fall lower and keep that in mind .

By looking at the market-cap and also the 1 year target it show 68.00 but I believe this will pull a $AQXP 2015 pump from under $5. I will hold and keep in radar here due to many Biotech industry has issue right now. 52- week high = $19.21 (today) with a  drop where it is now. FDA will control this STOCK !!!  1,662 is the number being follow on stock-twits. 

LAST SIGNAL:: STAY SHORT

LEVEL:: KEEP IN RADAR (WAIT UNTIL THE BIG DROP)

About Berkeley Lights Inc.

"The Berkeley Lights Platform accelerates the use of cell-based products. Our proprietary technology – automation, optimized workflows, software, consumables, assay reagents – enables scientists to find the best cells, the first time they look".